An evaluation of asciminib for patients with chronic myeloid leukemia previously treated with ≥2 tyrosine kinase inhibitors

  1. García-Gutiérrez, V.
  2. Hernandez-Boluda, J.C.
Aldizkaria:
Expert Review of Hematology

ISSN: 1747-4094,  1747-4086

Argitalpen urtea: 2022

Alea: 15

Zenbakia: 6

Orrialdeak: 477-484

Mota: Artikulua

DOI: 10.1080/17474086.2022.2080049 GOOGLE SCHOLAR
Datuen iturria: Scopus